Josef Koestler

1.2k total citations · 1 hit paper
10 papers, 836 citations indexed

About

Josef Koestler is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Josef Koestler has authored 10 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Virology. Recurrent topics in Josef Koestler's work include Gut microbiota and health (5 papers), HIV Research and Treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). Josef Koestler is often cited by papers focused on Gut microbiota and health (5 papers), HIV Research and Treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). Josef Koestler collaborates with scholars based in Germany, United States and Netherlands. Josef Koestler's co-authors include André Gessner, Daniel Wolff, Peter J. Oefner, Ernst Holler, Rainer Spang, Andreas Hiergeist, J. Hahn, Markus Weber, Daniela Weber and Katja Dettmer and has published in prestigious journals such as Blood, AIDS and Journal of General Virology.

In The Last Decade

Josef Koestler

10 papers receiving 833 citations

Hit Papers

Metagenomic Analysis of the Stool Microbiome in Patients ... 2014 2026 2018 2022 2014 100 200 300

Peers

Josef Koestler
Nicole Blijlevens Netherlands
E. Kurrle Germany
P J Darbyshire United Kingdom
Valle Nazar‐Stewart United States
Josef Koestler
Citations per year, relative to Josef Koestler Josef Koestler (= 1×) peers Elke Schäffeler

Countries citing papers authored by Josef Koestler

Since Specialization
Citations

This map shows the geographic impact of Josef Koestler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Koestler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Koestler more than expected).

Fields of papers citing papers by Josef Koestler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Koestler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Koestler. The network helps show where Josef Koestler may publish in the future.

Co-authorship network of co-authors of Josef Koestler

This figure shows the co-authorship network connecting the top 25 collaborators of Josef Koestler. A scholar is included among the top collaborators of Josef Koestler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Koestler. Josef Koestler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Salzberger, Bernd, Florian Hitzenbichler, Sebastian Einhauser, et al.. (2021). Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2. Vaccines. 9(10). 1089–1089. 37 indexed citations
2.
Simon, Michaela, Josef Koestler, Udo Reischl, André Gessner, & Jonathan Jantsch. (2019). Detection of carbapenemase-producing Enterobacterales and the BD Phoenix CPO Detect panel. Expert Review of Molecular Diagnostics. 19(8). 659–665. 5 indexed citations
3.
Weber, Daniela, Robert R. Jenq, Jonathan U. Peled, et al.. (2017). Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 23(5). 845–852. 161 indexed citations
4.
Weber, Daniela, Peter J. Oefner, Katja Dettmer, et al.. (2016). Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplantation. 51(8). 1087–1092. 86 indexed citations
5.
Weber, Daniela, Peter J. Oefner, Andreas Hiergeist, et al.. (2015). Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. Blood. 126(14). 1723–1728. 150 indexed citations
6.
Mooij, Petra, Gerrit Koopman, Jan W. Drijfhout, et al.. (2015). Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1. Journal of General Virology. 96(6). 1478–1483. 5 indexed citations
7.
Holler, Ernst, Karin Schmid‐Zalaudek, Christian Hundsrucker, et al.. (2014). Metagenomic analysis of the stool microbiome in patients receiving allogeneic SCT: Loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal GvHD. University of Regensburg Publication Server (University of Regensburg). 4 indexed citations
8.
Holler, Ernst, Karin Schmid‐Zalaudek, Christian Hundsrucker, et al.. (2014). Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 20(5). 640–645. 367 indexed citations breakdown →
9.
Koopman, Gerrit, Ivonne G. Nieuwenhuis, Gaby G. M. Doxiadis, et al.. (2013). DNA/long peptide vaccination against conserved regions of SIV induces partial protection against SIVmac251 challenge. AIDS. 27(18). 2841–2851. 20 indexed citations
10.
Koopman, Gerrit, Ivonne G. Nieuwenhuis, Petra Mooij, et al.. (2012). SIVconsv DNA prime - TLR7/IFNα adjuvanted long peptide boost induces potent CD4+ Ab responses and protects against high dose intrarectal SIV challenge. Retrovirology. 9(S2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026